Cargando…

Stem Cells: Current Status and Therapeutic Implications

Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterog...

Descripción completa

Detalles Bibliográficos
Autor principal: Reddy, Kaladhar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699792/
https://www.ncbi.nlm.nih.gov/pubmed/33233552
http://dx.doi.org/10.3390/genes11111372
_version_ 1783616131390504960
author Reddy, Kaladhar B.
author_facet Reddy, Kaladhar B.
author_sort Reddy, Kaladhar B.
collection PubMed
description Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterogeneity is originating from CSCs and its progenitors are recognized as major difficulty in efficaciously treating cancer patients. Therefore, understanding the biological mechanisms by which CSCs survive chemo- and-radiation therapy has the potential to identify new therapeutic strategies in the future. In this review, we summarized recent advances in CSC biology and their environment, and discuss about the potential therapies to prevent therapeutic resistance.
format Online
Article
Text
id pubmed-7699792
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76997922020-11-29 Stem Cells: Current Status and Therapeutic Implications Reddy, Kaladhar B. Genes (Basel) Review Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterogeneity is originating from CSCs and its progenitors are recognized as major difficulty in efficaciously treating cancer patients. Therefore, understanding the biological mechanisms by which CSCs survive chemo- and-radiation therapy has the potential to identify new therapeutic strategies in the future. In this review, we summarized recent advances in CSC biology and their environment, and discuss about the potential therapies to prevent therapeutic resistance. MDPI 2020-11-20 /pmc/articles/PMC7699792/ /pubmed/33233552 http://dx.doi.org/10.3390/genes11111372 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Reddy, Kaladhar B.
Stem Cells: Current Status and Therapeutic Implications
title Stem Cells: Current Status and Therapeutic Implications
title_full Stem Cells: Current Status and Therapeutic Implications
title_fullStr Stem Cells: Current Status and Therapeutic Implications
title_full_unstemmed Stem Cells: Current Status and Therapeutic Implications
title_short Stem Cells: Current Status and Therapeutic Implications
title_sort stem cells: current status and therapeutic implications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699792/
https://www.ncbi.nlm.nih.gov/pubmed/33233552
http://dx.doi.org/10.3390/genes11111372
work_keys_str_mv AT reddykaladharb stemcellscurrentstatusandtherapeuticimplications